Satellite Symposia

 

Sunday 29th May 2016 (14:15 – 15:30)

Room: Main Auditorium

Improved Assessment – Enhancing the Journey of People with Acromegaly

Chair: Andrea Giustina (Italy)

Introduction
Andrea Giustina (Italy)

Acromegaly: My Journey
Patient 

Shortening the Journey to Diagnosis and Treatment
Peter Kamenický (France)

Personalising the Management of Acromegaly
Stephan Petersenn (Germany)

Enhancing Long-term Outcomes in Acromegaly
Mark Gurnell (UK), with Patient 

Conclusion and Close
Andrea Giustina (Italy)

 

 

 


Sunday  29th  May 2016 (14.15 – 15:30)

Room: Saal 13A

Adrenal insufficiency: understanding patients to optimise treatment

Chair: Paul Stewart, University of Leeds, UK 

Care of the AI patient: a physician’s perspective
Marcus Quinkler (Germany)

 

DEBATE FOR: This house believes that immediate-release hydrocortisone is sufficient to optimise glucocorticoid replacement therapy in a patient with adrenal insufficiency

Paul Carroll (London, UK)

                                                                                                       

DEBATE AGAINST: This house believes that immediate-release hydrocortisone is sufficient to optimise glucocorticoid replacement therapy in a patient with adrenal insufficiency

Klaus Badenhoop (Germany)

 

Audience vote

Sunday 29th May 2016 (18:00-19:30)

Room: Main Auditorium

Benchmark your practice in Cushing’s syndrome

Co-chairs: John Newell-Price (UK), Richard Feelders (Netherlands)

Does my practice in Cushing's syndrome management differ from the ERCUSYN (European Register on Cushing's syndrome) experience?
Elena Valassi (Spain)

How do I measure cortisol levels in Cushing's syndrome patients in my daily practice?
Leo Niskanen (Finland) 

For which patients and when do I go for a bilateral adrenalectomy?
Frédéric Castinetti (France)

 

 

 

Sunday 29th May 2016 (18:00–19:30)

Room: Saal 5

Holistic disease management in acromegaly – Introducing the new tool ACRODAT

Chair: Ezio Ghigo (Italy)

Welcome and introduction
Ezio Ghigo (Italy)

Case for IGF-I as the biochemical marker to determine disease activity
Christian Strasburger (Germany)

Goldern rules for tumour volume assessment
Michael Buchfelder (Germany)

Considerations in the management of co-morbidities
David Clemmons (USA) 

Value of standardised symptoms and QoL measurements
Xavier Badia (Spain) 

A combined disease activity evaluation through ACRODAT
Thierry Brue (France) 

Closing remarks
Ezio Ghigo (Italy)

 

 

 

Monday 30th May 2016 (14:15 – 15:30)

Room: Main Auditorium

Next Steps in the Treatment of Pituitary Tumours

Co-chairs: John Newell-Price (UK), Mônica Gadelha (Brazil)

Welcome and introduction
John Newell-Price (UK)

Uncontrolled acromegaly: Challenging clinical decision-making
Mônica Gadelha (Brazil) & Christof Schôfl (Germany) 

New treatments on the horizon in Cushing’s disease
Rosario Pivonello (Italy) & John Newell-Price (UK)

Symposium conclusion and close
Mônica Gadelha (Brazil)

                               

 

Monday 30th May 2016 (14.15 – 15.30)

Room: Saal 13A

Current challenges in the management of hypoparathyroidism

Chair: Walter Josef Fassbender (Switzerland)

Overview of hypoparathyroidism: aetiology and burden of illness
Stefanie Hahner (Germany)                                                                                                          

Management of hypoparathyroidism: short-term challenges and long-term consequences             
Maria Luisa Brandi (Italy)

Case studies: patient perspectives and physician experience
Panel